» Articles » PMID: 25585877

The Relationship Between CCR6 and Its Binding Partners: Does the CCR6-CCL20 Axis Have to Be Extended?

Overview
Journal Cytokine
Date 2015 Jan 15
PMID 25585877
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Chemokines and their receptors are vital for the trafficking of immune cells. In an orchestrated fashion, up- and down-regulation of chemokines and their receptors contribute to both immune system homeostasis as well as inflammation. The CC chemokine, CCL20 and its cognate receptor, CCR6, are described as one of the few chemokine-receptor pairs that show exclusivity. In our review, we analyze observations which indicate that CCR6 does not have CCL20 as an exclusive ligand as once appreciated. For example, attempts to study the pair, utilizing mainly CCR6-deficient mice, are confounded by a family of non-chemokine ligands known as β-defensins that can bind to CCR6 and potentially can activate the cell. Therefore, a review of the activities of other potential binding partners of CCR6 is essential for interpretation of the current literature on this matter and for an understanding of their involvement in basic immunology and pathology.

Citing Articles

Progress of CCL20-CCR6 in the airways: a promising new therapeutic target.

Li Y, Geng W, Li C, Wu J, Gao F, Wang Y J Inflamm (Lond). 2024; 21(1):54.

PMID: 39731176 PMC: 11681768. DOI: 10.1186/s12950-024-00427-5.


The Chemokine, CCL20, and Its Receptor, CCR6, in the Pathogenesis and Treatment of Psoriasis and Psoriatic Arthritis.

Shi Z, Mabuchi T, Riutta S, Wu X, Peterson F, Volkman B J Psoriasis Psoriatic Arthritis. 2024; 8(3):107-117.

PMID: 39296310 PMC: 11361516. DOI: 10.1177/24755303231159106.


Prognostic Value of Macrophage Inflammatory Protein-3alpha (MIP3-Alpha) and Severity Scores in Elderly Patients with Sepsis.

Liu M, Duan Y, Zhang Y, Yang J, Wei B, Wang J J Inflamm Res. 2024; 17:1503-1509.

PMID: 38476471 PMC: 10929558. DOI: 10.2147/JIR.S447142.


IκBζ is an essential mediator of immunity to oropharyngeal candidiasis.

Taylor T, Coleman B, Arunkumar S, Dey I, Dillon J, Ponde N Cell Host Microbe. 2023; 31(10):1700-1713.e4.

PMID: 37725983 PMC: 10591851. DOI: 10.1016/j.chom.2023.08.016.


CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases.

Gomez-Melero S, Caballero-Villarraso J Antibodies (Basel). 2023; 12(2).

PMID: 37092451 PMC: 10123731. DOI: 10.3390/antib12020030.